The Week That Was

Published on April 10, 2020

General Practice Updates

In a constantly changing environment, we summarise the most important updates for General Practitioners. 

This week’s summary includes updates from:

  • AHPRA
  • Department of Health

 

AHPRA

Changes to presenting-in-person requirements – 

In response to social distancing and isolation requirements, AHPRA has made changes to the presenting-in- person requirements for international medical graduates. Applicants who hold current in-principle approval of registration and are currently in Australia only have to present to their intended place of employment to have their identity verified and their identity documents certified by a registered health practitioner. 

Normally, applicants who applied for registration overseas would have to present to their intended place of work and also an AHPRA office so their identity is verified by both organizations before their registration is finalised. 

Currently, proof of identity documents need to be certified by a registered health practitioner and then submitted to AHPRA via email. 

Read More: https://www.ahpra.gov.au/News/2020-03-27-Changes-to-presenting-in-person-requirements.aspx

 

DEPARTMENT OF HEALTH

Advice on off-label medicines for treatment and prophylaxis of COVID-19 – 

The Australian Health Protection Principal Committee (AHPPC) has acknowledged that there is currently very limited evidence to support the use of medications to treat COVID-19. There are several medications that are currently being trialled both within Australia and globally to test their efficacy and safety. Broadly, these are the medication classes that have been suggested: 

  • Antimalarial drugs (such as chloroquine and hydroxychloroquine)
  • Antivirals (such as favipiravir, umifenovir, remdesivir)
  • Antiretrovirals (such as Ritonavir + Lopinavir (“Kaletra”))
  • Immune modulators (Interferon α, β, γ or λ; β looks most promising)
  • Biologic Disease Modifying Anti-Rheumatic Drugs (Interleukin-6 inhibitors, such as tocilizumab and sarilumab)

However due to safety concerns and the unknown effects of prescribing these medications, AHPPC does not recommend the use of these medications. 

 Read More: https://www.health.gov.au/news/australian-health-protection-principal-committee-ahppc-coronavirus-covid-19-statements-on-7-april-2020

 

DID WE MISS SOMETHING IMPORTANT?

We’re here to help. If there is something we’re missing, please let us know! Our team are available at marketing@peoplemedical.com.au 

 

DO YOU HAVE QUESTIONS? 

Our team offer General Practitioners assistance with finding jobs and a career pathway, and Medical Facilities to find a new Medical Practitioner. We also help with the full application process with AHPRA, RACGP, ACRRM, Department of Health, Medicare including 19AA & 19AB. If we can help, please contact us at help@peoplemedical.com.au

 

 

People Medical Consulting are a team of professionals with a passion for guiding those specialising in the Medical industry to find their career pathway and settle into Australia. Working with both Australian trained and Overseas trained professionals, we have extensive experience in Recruitment of General Practitioners and Document Assistance for those requiring support with RACGP, AHPRA, 19AA and 19AB Medicare Exemptions.